β-Blocker use is associated with a higher relapse risk of inflammatory bowel disease: a Dutch retrospective case–control study

Rose Willemze, Wouter J. de Jonge, Tinka Bakker et al.|European Journal of Gastroenterology & Hepatology|2017

Cited by 27